Christiane Riedinger

发表

All change: protein conformation and the ubiquitination reaction cascade

J. Endicott, Christiane Riedinger, 2009, F1000 biology reports.

Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12*

N. Brown, J. Endicott, M. Noble, 2010, The Journal of Biological Chemistry.

Analysis of chemical shift changes reveals the binding modes of isoindolinone inhibitors of the MDM2-p53 interaction.

M. Noble, J. Endicott, I. Hardcastle, 2008, Journal of the American Chemical Society.

MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinones.

M. Noble, J. Endicott, J. Lunec, 2011, Bioorganic & medicinal chemistry letters.

Inhibitors of MDM2 and MDMX: a structural perspective.

Christiane Riedinger, J. McDonnell, 2009, Future medicinal chemistry.

Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12*

N. Brown, J. Endicott, M. Noble, 2010, The Journal of Biological Chemistry.

The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment

G. Guyatt, M. Bretthauer, I. Lansdorp-Vogelaar, 2021, PloS one.

Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction.

M. Noble, J. Endicott, G. Chessari, 2021, Journal of medicinal chemistry.

Analysis of the components of cancer risk perception and links with intention and behaviour: A UK-based study

W. Klein, R. Ferrer, J. Usher-Smith, 2022, PloS one.

The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant.

M. Noble, J. Endicott, Christiane Riedinger, 2013, Acta crystallographica. Section D, Biological crystallography.

Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potency.

M. Noble, J. Endicott, J. Lunec, 2011, Journal of medicinal chemistry.

Understanding Small‐Molecule Binding to MDM2: Insights into Structural Effects of Isoindolinone Inhibitors from NMR Spectroscopy

M. Noble, J. Endicott, Florian F. Mulks, 2011, Chemical biology & drug design.

Structural and functional characterization of Rpn12 identifies residues required for Rpn10 proteasome incorporation

J. Endicott, M. Noble, E. Lowe, 2012, The Biochemical journal.

Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12*

J. Endicott, K. Gehring, J. Trempe, 2010, The Journal of Biological Chemistry.

The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant.

M. Noble, J. Endicott, Christiane Riedinger, 2013, Acta crystallographica. Section D, Biological crystallography.